Tweets by scisetglobal

Current: Biomedical Research

Current: Biomedical Research

ISSN:

Current: Biomedical Research aims to publish high quality original research work and provides a platform for scientists and academicians all over the world to promote, share, and discuss various novel aspects and methods in all areas of Biomedical Research including Cell biology, Omics technologies: genomics, transcriptomics, proteomics, metabolomics, pharmaceutical biomedicine, Physiology/biochemistry, and Regenerative medicine.

This journal serves the scientific community as a forum to discuss current developments in the area of Biomedical Research by exploring new innovations and application of genetic principles in medicine and public policy to attain highest publishing quality standards.

Current: Biomedical Research is an open access, peer-reviewed, multidisciplinary, scholarly publishing journal, who publishes the contributions in the form of research articles, scientific reviews, clinical trial evidence, short communications, case reports etc. We provide digital object identifier (DOI), which is electronic identification code or tag for all manuscripts and serves international readers by publishing the original manuscripts and other related research work submitted by worldwide authors.

Current: Biomedical Research also offering membership program, to initiate and accomplish the vision of making Healthcare & Scientific Information Open Access, enables academic and research institutions, societies, groups, funding organizations and corporations to actively support Open Access in scholarly publishing and support the participation of its representatives and students in international conferences.

Current: Biomedical Research offers distinct benefits to academic, government, universities, and corporate libraries as well as to authors, editors and readers upon associating with the Journal.

These Benefits include:

• Member can submit unlimited number of articles to any of the Journal.
• Member will avail a prestigious certificate of Annual membership from Journal.
• Entrepreneurial, personalized approach to publishing process
• High media visibility and discoverability of published content
• Publications with high-quality guided by international researchers and experts
• Flexible licensing agreements.
• Serve the Editorial Board as reviewer or member for Current: Biomedical Research.
• Archiving in perpetuity

Editorial Board

The initial manuscript handling persons are Editorial Board Members. The decision from them will be communicated to Editor-in-Chief/Managing Editor. If assertive comments from all ends, the manuscript will go for rigorous peer-review. In all the cases stated above, only the recognized experts in the respective field will be allowed to comment on the manuscript.

Peer Review

The single manuscript will be assigned to multiple reviewers and the most logical and elaborated comments will be accepted for evaluation. In no condition, peer-review process will be extended more than 14 days.

Managing Editor’s Role

Managing Editor's will follow up and provide adequate responses regarding the manuscript assigned to him/her. Managing Editor’s will not interfere in the decision-making process of the manuscript. In a critical situation, the managing editor will assign the manuscript to the additional reviewer in case the review process is delayed or lack of communication with the reviewer.

Rapid and Fast Publication

All segments of the manuscript processing-related communications are transparent, rapid, and effortless which in other way helps to complete the article processing within the promised timeline.

Submission Process

Authors may submit the manuscript either online or as an email attachment to submissions@sciset.com